Three‐arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non–small cell lung cancer (NSCLC) patients who will not receive bevacizumab‐based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508)

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2253-2261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 491-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intensity‐modulated radiotherapy for elderly patients with nasopharyngeal carcinoma

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 590-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

By  

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2422-2430

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparative dosimetric study comparing dose to the carotid artery using 3D conformal radiotherapy and intensity-modulated radiotherapy for T1-T2 glottic cancer at Gharbia Cancer Society, Egypt

By  

Journal of Radiotherapy in Practice, Vol. 16, Iss. 2, 2017-02 ,pp. : 177-182

Cambridge University Press

Access to resources Recommend Favorite